Cargando…
Early Life Abuse Moderates the Effects of Intranasal Oxytocin on Symptoms of Premenstrual Dysphoric Disorder: Preliminary Evidence From a Placebo-Controlled Trial
Background: Although intranasal oxytocin (OXT) has been proposed to be a promising treatment for some psychiatric disorders, little research has addressed individual difference factors that may predict response to OXT. One such factor is early life abuse (ELA), which has widespread influences on soc...
Autores principales: | Walsh, Erin C., Eisenlohr-Moul, Tory A., Pedersen, Cort A., Rubinow, David R., Girdler, Susan S., Dichter, Gabriel S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282546/ https://www.ncbi.nlm.nih.gov/pubmed/30555357 http://dx.doi.org/10.3389/fpsyt.2018.00547 |
Ejemplares similares
-
Top 100 Cited Papers on Premenstrual Syndrome/Premenstrual Dysphoric Disorder: A Bibliometric Study
por: Gao, Mingzhou, et al.
Publicado: (2022) -
Comorbid Premenstrual Dysphoric Disorder and Bipolar Disorder: A Review
por: Slyepchenko, Anastasiya, et al.
Publicado: (2021) -
The Prominent Role of the Temporal Lobe in Premenstrual Syndrome and Premenstrual Dysphoric Disorder: Evidence From Multimodal Neuroimaging
por: Long, Jingyi, et al.
Publicado: (2022) -
Brain Structure and Function in Women with Comorbid Bipolar and Premenstrual Dysphoric Disorder
por: Syan, Sabrina K., et al.
Publicado: (2018) -
Prevalence of lifetime self-injurious thoughts and behaviors in a global sample of 599 patients reporting prospectively confirmed diagnosis with premenstrual dysphoric disorder
por: Eisenlohr-Moul, Tory, et al.
Publicado: (2022)